Up a level |
van Haren, Frank MP, Page, Clive, Laffey, John G, Artigas, Antonio, Camprubi-Rimblas, Marta, Nunes, Quentin ORCID: 0000-0002-7513-8595, Smith, Roger, Shute, Janis, Carroll, Mary, Tree, Julia et al (show 4 more authors)
(2020)
Nebulised heparin as a treatment for COVID-19: scientific rationale and a call for randomised evidence.
CRITICAL CARE, 24 (1).
454-.
Killingley, Ben, Mann, Alex, Kalinova, Mariya ORCID: 0000-0002-3744-4604, Boyers, Alison, Goonawardane, Niluka ORCID: 0000-0003-2906-5513, Zhou, Jie, Lindsell, Kate, Hare, Samanjit, Brown, Jonathan ORCID: 0000-0001-6849-3962, Frise, Rebecca et al (show 21 more authors)
(2022)
Safety, tolerability and viral kinetics during SARS-CoV-2 human challenge.
ResearchSquare.
Killingley, Ben, Mann, Alex J, Kalinova, Mariya, Boyers, Alison, Goonawardane, Niluka, Zhou, Jie, Lindsell, Kate, Hare, Samanjit S, Brown, Jonathan, Frise, Rebecca et al (show 21 more authors)
(2022)
Safety, tolerability and viral kinetics during SARS-CoV-2 human challenge in young adults.
NATURE MEDICINE, 28 (5).
1031-+.
Tree, Julia A, Turnbull, Jeremy E ORCID: 0000-0002-1791-754X, Buttigieg, Karen R, Elmore, Michael J, Coombes, Naomi, Hogwood, John, Mycroft-West, Courtney J, Lima, Marcelo A, Skidmore, Mark A, Karlsson, Richard et al (show 10 more authors)
(2021)
Unfractionated heparin inhibits live wild type SARS-CoV-2 cell infectivity at therapeutically relevant concentrations.
BRITISH JOURNAL OF PHARMACOLOGY, 178 (3).
pp. 626-635.